Larvol Delta - Mateon-Achieves-Milestone-in-its-Development-of-OT101-a-Phase-3-Clinical-Drug-Candidate-Against-COVID19

trabedersen (OT-101) - Autotelic, Mateon Therapeutics

http://www.globenewswire.com/news-release/2020/04/06/2012085/0/en/Mateon-Achieves-Milestone-in-its-Development-of-OT-101-a-Phase-3-Clinical-Drug-Candidate-Against-COVID-19.html

Apr 6, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next